Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Interius BioTherapeutics logo — Interius is developing new ways to engineer cells inside the...

Interius BioTherapeutics

Interius is developing new ways to engineer cells inside the human body, right where they live

Founded 2019 United States Philadelphia, United States 19 employees Acquired Total: $504.43M Biopharma, Biotechnology +2

General Information

Company Name Interius BioTherapeutics
Founded Year 2019
Location United States Philadelphia, United States
Employees 19
Industries Biopharma, Biotechnology, Health Care +1
Funding Stage Acquired
Business Model B2B
Revenue Model Licensing, Product Sales, Service Fee
Social

BounceWatch is an independent company data service, not affiliated with Interius BioTherapeutics. To contact Interius BioTherapeutics, visit interiusbio.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Interius BioTherapeutics compare?

A PDF of Interius BioTherapeutics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Interius BioTherapeutics soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Interius BioTherapeutics

Interius BioTherapeutics is at the forefront of transforming cell engineering by developing innovative techniques to modify cells directly within the human body, as captured in their slogan: "Interius is developing new ways to engineer cells inside the human body, right where they live."

Founded in 2019, the company operates primarily in the Biopharma, Biotechnology, and Health Care industries. Interius BioTherapeutics is headquartered in the United States and has become a part of Kite, a Gilead Company, following a strategic acquisition. Kite Pharma, known for its cutting-edge advancements in cell therapy and headquartered in Santa Monica, California, invested a substantial $350.00M in this acquisition on 01 August 2025.

This acquisition underscores Kite Pharma's commitment to expanding its portfolio in the biopharmaceutical sector by integrating Interius BioTherapeutics' groundbreaking in-body cell engineering technologies into its existing operations to drive future innovations.

Business keywords: in vivo gene therapy, cell engineering, B cell lymphomas treatment, intravenous CAR treatment, target tissue specificity, autoimmune conditions therapy, gene medicines, biopharmaceuticals, cell-specific therapy, precision medicine, therapy without chemotherapy, expanded care settings

Services & Products

Development of Genetic Medicines
Engineering of Targeted Vectors
Clinical Trials for Therapeutics
Research and Development in Oncology
Development of Autoimmunity Treatments

Target Customers

Patients with Challenging Diseases Healthcare Providers Medical Researchers Biotechnology Investors Pharmaceutical Companies

Funding Rounds & Investors (6)

View All
Funding Stage Amount Investors Lead Investors Date
Acquisition $350.00M 1
Kite Pharma
Kite Pharma
01 Aug 2025
Early VC $51.43M -
01 Jun 2024
Debt Financing $21.50M -
01 Oct 2023
Series A $76.00M 15
Longwood Fund RA Capital Management BrightEdge Ventures
Longwood Fund, RA Capital Management +13
01 May 2021
Early VC $5.50M 6
Agent Capital Penn Medicine Tellus BioVentures
Agent Capital, Penn Medicine +4
01 Mar 2020
Spinout Undisclosed 1
University of Pennsylvania
01 Jan 2019

Interius BioTherapeutics Alternatives & Competitors

View All Alternatives
Interius BioTherapeutics vs
Arcellx
Arcellx United States

Arcellx is a clinical-stage biotechnology company based in Redwood City, California

Acquired
224 employees
Biopharma, Biotechnology
Compare Interius BioTherapeutics vs Arcellx
Interius BioTherapeutics vs
Basilard BioTech, Inc.
Basilard BioTech, Inc. United States

Nanomechanical Gene Delivery to Transform the Engineering of Cell Based Therapies

Seed
5 employees
Biopharma, Biotechnology
Interius BioTherapeutics vs
Gracell Biotechnologies
Gracell Biotechnologies China

A Member of the AstraZeneca Group

Acquired
33 employees
Biotechnology, Health Care
Also compare with: Interius BioTherapeutics vs Tubulis GmbH Tubulis GmbH View all alternatives

FAQ About Interius BioTherapeutics

Interius is developing new ways to engineer cells inside the human body, right where they live
Interius BioTherapeutics was founded in 2019.
Interius BioTherapeutics is headquartered in Philadelphia, United States.
Interius BioTherapeutics operates in Biopharma, Biotechnology, Health Care and Health and Wellness. Its work centres on in vivo gene therapy, cell engineering, B cell lymphomas treatment and intravenous CAR treatment. Its customers include Patients with Challenging Diseases, Healthcare Providers and Medical Researchers.
Interius BioTherapeutics has a B2B business model. Its revenue comes from Licensing, Product Sales and Service Fee.
Interius BioTherapeutics has approximately 19 employees.
Interius BioTherapeutics has completed 6 funding rounds, raising a total of $504.43M. The latest funding stage is Acquired.
Interius BioTherapeutics offers: Development of Genetic Medicines, Engineering of Targeted Vectors, Clinical Trials for Therapeutics, Research and Development in Oncology, Development of Autoimmunity Treatments.
Top alternatives and competitors to Interius BioTherapeutics include Arcellx, Basilard BioTech, Inc., Gracell Biotechnologies, GenEdit, Ensoma. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Interius BioTherapeutics and Arcellx are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Interius BioTherapeutics, https://bouncewatch.com/company/interius-biotherapeutics, updated 15 June 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes